C, Tan S, Berkowitz K, Hodis HN, Azen SP 2002 Preservation of pancreatic /H9252-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796 –2803 11.Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M 2002 Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM ran-domized trial. Lancet 15:2072 –2077 12.Bhavsar S, Lachappell R, Watkins J, Young A 1998 Comparison of glucose- lowering effects of exendin-4 and GLP-1 in diabetic db/db mice. Diabetes47:192A (Abstract) 13.Egan JM, Clocquet AR, Elahi D 2002 The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2diabetes. J Clin Endocrinol Metab 87:1282 –1290 14.Parkes DG, Pittner R, Jodka C, Smith P, Young A 2001 Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 50:583 –589